Trade deal to boost U.S. demand for Korean generics

Published: 2007-04-12 07:00:00

Updated: 2007-04-12 07:00:00

Korean generic makers will enjoy a boost in demand from the U.S. market thanks to the free trade agreement sealed between Korea and the United States, experts said.

Korean pharmaceutical firms can win many orders from the United States, because what they charge for designing is about one third...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK